Use of Pulsatile Intravenous FSH to Mitigate Reprometabolic Syndrome

PHASE1RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 1, 2024

Primary Completion Date

November 30, 2025

Study Completion Date

November 30, 2026

Conditions

InfertilityObesity

Interventions

DRUG

Follicle Stimulating Hormone

Pulsatile FSH administration via a portable pump.

Trial Locations (1)

RECRUITING

University of Colorado Anschutz Medical Campus, Aurora

All Listed Sponsors

lead

University of Colorado, Denver

OTHER